PeptiENV

N/A

Report date: 2025/01/26 16:51:57

Base Information

Drug NamePeptiENV
Drug Alias NameTumor-specific peptide-coated oncolytic virus therapy (Valo Therapeutics)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Helsinki
China Registration ClassN/A

Develop Information

Active CompaniesAvalo Therapeutics Inc
Inactive CompaniesUniversity Of Helsinki
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A